ASX healthcare shares have largely struggled in 2026. However these three oversold options could now be a value play.
Fortescue Ltd (ASX: FMG) accelerates its large-scale green industry energy grid, cutting fossil fuel costs and advancing ...
A $2,000 investment can be the start of something meaningful. Breville offers global consumer growth, Xero provides exposure ...
S&P/ASX 200 Index (ASX: XJO) shares fell steeply in March due to the war in Iran. Which stocks are now good value, according ...
ASX retail stocks Lovisa and Nick Scali have both been hit hard in 2026. But that’s exactly what makes these expanding ...
ASX 200 mining shares were the worst hit by the war in Iran last month. Here's what three market experts think of these ...
Xero Ltd (ASX: XRO) shares are down over 60% from their high. Here are three reasons that this could be a buying opportunity ...
ASX stocks REA Group and Aristocrat have both lost around 30% recently. Investors may want to take a closer look as brokers ...
Telix Pharmaceuticals Ltd (ASX: TLX) share price in focus as FDA accepts NDA for Pixclara, a glioma imaging agent.
Life360 Inc (ASX: 360) shares are down but not out according to Bell Potter. Here's why it thinks they could rise ...
Bendigo and Adelaide Bank Ltd (ASX: BEN) jumped higher on Thursday, recouping losses seen in late-February and March.
These ASX dividend shares have lost up to 20% in 2026. Dexus, Mirvac and Charter Hall are now offering higher yields and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results